Showing results (51-60 of 127) with videos related to
Sort By:
Pageof 13
Genetic Testing|April 19, 2002
A primer for predicting risk of disease in HFE-linked hemochromatosisP C Adams, A P Walker, R T ActonClinical and Investigative Medicine. Medecine Clinique Et Experimentale|April 1, 1997
Factors affecting glucose tolerance in hereditary hemochromatosisI M Hramiak, D T Finegood, P C AdamsHepatology (Baltimore, Md.)|December 1, 1995
Screening for hemochromatosis in children of homozygotes: prevalence and cost-effectivenessP C Adams, A E Kertesz, L S ValbergHepatology (Baltimore, Md.)|January 1, 1997
The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosisP C Adams, Y Deugnier, R Moirand, et al.European Heart Journal|March 1, 1992
Septal rupture after myocardial infarction: is very early surgery really worthwhile?G Parry, J Goudevenos, P C Adams, et al.Blood Cells, Molecules & Diseases|February 8, 2000
HFE S65C variant is not associated with increased transferrin saturation in voluntary blood donorsN Arya, S Chakrabrati, R A Hegele, et al.British Journal of Clinical Pharmacology|October 1, 1983
Plasma digoxin: assay anomalies in Fab-treated patientsI Gibb, P C Adams, A J Parnham, et al.Journal of the American College of Cardiology|December 1, 1986
Thrombosis and embolism from cardiac chambers and infected valvesP C Adams, M Cohen, J H Chesebro, et al.Current Medical Research and Opinion|February 24, 2001
Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS study)F Garmendia, A S Brown, I Reiber, et al.American Journal of Hematology|August 1, 1991
Expression of transferrin receptors on monocytes in hemochromatosisP C Adams, L A Chau, M White, et al.Pageof 13